Humacyte Inc (HUMA)
6.33
-0.09
(-1.40%)
USD |
NASDAQ |
May 17, 16:00
6.35
+0.02
(+0.32%)
After-Hours: 20:00
Humacyte Total Assets (Quarterly): 161.47M for March 31, 2024
Total Assets (Quarterly) Chart
Historical Total Assets (Quarterly) Data
Date | Value |
---|---|
March 31, 2024 | 161.47M |
December 31, 2023 | 128.22M |
September 30, 2023 | 149.38M |
June 30, 2023 | 168.11M |
March 31, 2023 | 182.98M |
December 31, 2022 | 204.30M |
Date | Value |
---|---|
September 30, 2022 | 226.22M |
June 30, 2022 | 246.36M |
March 31, 2022 | 264.47M |
December 31, 2021 | 286.53M |
September 30, 2021 | 303.36M |
December 31, 2020 | 106.69M |
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
106.69M
Minimum
Dec 2020
303.36M
Maximum
Sep 2021
202.34M
Average
193.64M
Median
Total Assets (Quarterly) Benchmarks
Aquestive Therapeutics Inc | 129.52M |
Adial Pharmaceuticals Inc | 4.737M |
Gritstone Bio Inc | 137.21M |
Precision BioSciences Inc | 184.74M |
Puma Biotechnology Inc | 214.15M |
Total Assets (Quarterly) Related Metrics
Total Liabilities (Quarterly) | 135.31M |
Shareholders Equity (Quarterly) | 26.15M |